Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
44.38
+0.80 (1.84%)
At close: Jun 18, 2026, 4:00 PM EDT
44.38
0.00 (-0.01%)
After-hours: Jun 18, 2026, 4:24 PM EDT
Supernus Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Supernus Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $62.83. The average 1-year stock price forecast is 41.57% higher than the current stock price, while the lowest is $55 (+23.93%) and the highest is $66 (+48.72%).
Price Target: $62.83 (+41.57%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Supernus Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $66 | Buy | Maintains | $66 | +48.72% | Jun 4, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $55 | Hold | Maintains | $55 | +23.93% | May 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $65 | Buy | Maintains | $65 | +46.46% | May 6, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $60 → $65 | Buy | Maintains | $60 → $65 | +46.46% | Mar 24, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $65 | Buy | Maintains | $65 | +46.46% | Feb 25, 2026 |
Financial Forecast
Revenue This Year
867.26M
from 718.95M
Increased by 20.63%
Revenue Next Year
1.02B
from 867.26M
Increased by 17.60%
EPS This Year
2.49
from 2.40
Increased by 3.82%
EPS Next Year
4.34
from 2.49
Increased by 74.66%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 872.5M | ||
| Avg | 867.3M | ||
| Low | 859.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.4% | ||
| Avg | 20.6% | ||
| Low | 19.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 2.49 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 3.8% | ||
| Low | - |